These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38141930)

  • 1. Comprehensive genomic profiling of small bowel adenocarcinoma by tissue and plasma biopsy.
    Yu D; Wang J; Zheng B; Yuan M; Gu D; Chen R; Chen X
    Genomics; 2024 Jan; 116(1):110766. PubMed ID: 38141930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma.
    Pan H; Cheng H; Wang H; Ge W; Yuan M; Jiang S; Wan X; Dong Y; Liu Z; Zhao R; Fang Y; Lou F; Cao S; Han W
    Cancer Sci; 2021 Nov; 112(11):4758-4771. PubMed ID: 34449929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Profiling of Small-Bowel Adenocarcinoma.
    Schrock AB; Devoe CE; McWilliams R; Sun J; Aparicio T; Stephens PJ; Ross JS; Wilson R; Miller VA; Ali SM; Overman MJ
    JAMA Oncol; 2017 Nov; 3(11):1546-1553. PubMed ID: 28617917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer.
    Lin Z; Li Y; Tang S; Deng Q; Jiang J; Zhou C
    Lung Cancer; 2023 Aug; 182():107282. PubMed ID: 37392713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driver and targetable alterations in Chinese patients with small bowel carcinoma.
    Li J; Li X; Dong N; Yan S; Jing C; Ma T; Li W; Zhang C; Cai Y; Deng W
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6139-6150. PubMed ID: 36680582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Landscape of Small Bowel Adenocarcinoma.
    Pandya K; Overman MJ; Gulhati P
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling.
    Guo Z; Xie Z; Shi H; Du W; Peng L; Han W; Duan F; Zhang X; Chen M; Duan J; Lin J; Chen X; Lizaso AA; Han-Zhang H; He J; Yin W
    Thorac Cancer; 2019 Apr; 10(4):823-831. PubMed ID: 30779318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA.
    Chae YK; Davis AA; Carneiro BA; Chandra S; Mohindra N; Kalyan A; Kaplan J; Matsangou M; Pai S; Costa R; Jovanovic B; Cristofanilli M; Platanias LC; Giles FJ
    Oncotarget; 2016 Oct; 7(40):65364-65373. PubMed ID: 27588476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing.
    Tatsuguchi A; Yamada T; Ueda K; Furuki H; Hoshimoto A; Nishimoto T; Omori J; Akimoto N; Gudis K; Tanaka S; Fujimori S; Shimizu A; Iwakiri K
    BMC Cancer; 2022 Jul; 22(1):723. PubMed ID: 35778698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
    Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
    Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers.
    Haan JC; Buffart TE; Eijk PP; van de Wiel MA; van Wieringen WN; Howdle PD; Mulder CJ; van de Velde CJ; Quirke P; Nagtegaal ID; van Grieken NC; Grabsch H; Meijer GA; Ylstra B
    Ann Oncol; 2012 Feb; 23(2):367-74. PubMed ID: 21586687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway.
    Adam L; San Lucas FA; Fowler R; Yu Y; Wu W; Liu Y; Wang H; Menter D; Tetzlaff MT; Ensor J; Manyam G; Arold ST; Huff C; Kopetz S; Scheet P; Overman MJ
    Clin Cancer Res; 2019 Jan; 25(2):641-651. PubMed ID: 30352910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
    Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
    J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome-wide somatic mutation characterization of small bowel adenocarcinoma.
    Hänninen UA; Katainen R; Tanskanen T; Plaketti RM; Laine R; Hamberg J; Ristimäki A; Pukkala E; Taipale M; Mecklin JP; Forsström LM; Pitkänen E; Palin K; Välimäki N; Mäkinen N; Aaltonen LA
    PLoS Genet; 2018 Mar; 14(3):e1007200. PubMed ID: 29522538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma.
    Hoshimoto A; Tatsuguchi A; Yamada T; Kuriyama S; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Gudis K; Mitsui K; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
    Am J Surg Pathol; 2024 Feb; 48(2):127-139. PubMed ID: 38062562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine.
    Pagès M; Rotem D; Gydush G; Reed S; Rhoades J; Ha G; Lo C; Fleharty M; Duran M; Jones R; Becker S; Haller M; Sinai CE; Goumnerova L; Golub TR; Love JC; Ligon KL; Wright KD; Adalsteinsson VA; Beroukhim R; Bandopadhayay P
    Neuro Oncol; 2022 Aug; 24(8):1352-1363. PubMed ID: 34984433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
    Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
    J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Molecular Features and Treatment Options for Small Bowel Adenocarcinoma.
    Cordova-Delgado M; Pizarro G; Pinto MP; Herrera ME; Garrido M
    Front Oncol; 2021; 11():593561. PubMed ID: 33777741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.